Enroxil Flavour 15 mg Enrofloxacin Tablets for dogs and cats


Enroxil Flavour 15 mg Tablets for dogs and cats

Active substance:

Each tablet contains: Enrofloxacin 15 mg
Round slightly biconvex, cream to light brownish tablets with possible visible white or darker spots and bevel-edged .

Target species

Dogs and cats.

Indications for use, specifying the target species

The product is for use in dogs and cats in the treatment of bacterial infections of the alimentary, respiratory and urogenital tracts, skin, secondary wound infections and otitis externa where clinical experience, supported where possible by sensitivity testing of the causal organism, indicates enrofloxacin as the drug of choice.


Do not use in dogs less than 1 year of age or in exceptionally large breeds of dog with a longer growth period less than 18 months of age, as articular cartilage may be affected during the period of rapid growth.
Not recommended for use in cats less than 8 weeks of age.
Do not use in case of hypersensitivity to the active substance or to any of the excipients.
Do not use in dogs having seizure disorders, since enrofloxacin may cause CNS stimulation.

Special precautions for use in animals

Fluoroquinolones should be reserved for the treatment of clinical conditions
which have responded poorly, or are expected to respond poorly to other classes of antimicrobials.
Whenever possible, use of fluoroquinolones should be based on susceptibility testing. Use of the product deviating from the instructions given in the SPC may increase the prevalence of bacteria resistant to the fluoroquinolones and may decrease the effectiveness of treatment with other quinolones due to the potential for cross-resistance.
Official and local antimicrobial policies should be taken into account when the product is used.

The product should not be used for prophylaxis.
Do not exceed the recommended dosage.
Retinotoxic effects including blindness can occur in cat when the recommended dose is exceeded.

Use the product with caution in dogs with severe renal or hepatic impairment.

Special precautions to be taken by the person administering the veterinary medicinal product to animals

Wash hands after use.
In case of contact with the eyes, wash with plenty of clean water.
In case of accidental ingestion, seek medical advice immediately and show the package leaflet to the physician.
People with known hypersensitivity to fluoroquinolones should avoid contact with the product.

Adverse reactions (frequency and seriousness)

During the period of rapid growth, enrofloxacin may affect articular cartilage development.
In rare cases vomiting and anorexia are observed

Use during pregnancy, lactation or lay

Use only according to the benefit: risk assessment by the veterinary surgeon.

Interaction with other medicinal products and other forms of interaction

Do not combine with tetracyclines, phenicols or macrolides because of potential antagonistic effects.
Concurrent administration of fluoroquinolones may increase the action of oral anticoagulants.
Do not combine with theophylline as this could lead to a prolonged elimination of this substance.
Concurrent administration of magnesium or aluminum containing substances may be followed by retarded absorption of enrofloxacin.

Amounts to be administered and administration route

Do not exceed the recommended dosage. The dosage rate of enrofloxacin is 5 mg/kg given orally once daily or as a divided dose twice daily for 5 to 10 days with or without food.
The duration of treatment in dogs may be extended depending on the clinical response and the judgement of the responsible veterinary surgeon.
To ensure a correct dosage body weig

10 tablets

PRICE – £ 6.90


Add comment